Westwood Holdings Group’s Teva Pharmaceuticals TEVA Stock Holding History

Westwood Holdings Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,520	Closed	-$132K	–	508
2019 Q4	$132K	Hold	13,520	–	–	﹤0.01%	460
2019 Q3	$93K	Buy	13,520 +800	+6%	+$6.13K	﹤0.01%	450
2019 Q2	$117K	Buy	+12,720	New	+$153K	﹤0.01%	477
2017 Q3	–	Sell	-1,885	Closed	-$63K	–	500
2017 Q2	$63K	Buy	1,885 +430	+30%	+$13.3K	﹤0.01%	442
2017 Q1	$47K	Buy	1,455 +225	+18%	+$7.68K	﹤0.01%	392
2016 Q4	$45K	Buy	+1,230	New	+$49.1K	﹤0.01%	443
2013 Q4	–	Sell	-412,051	Closed	-$15.6M	–	326
2013 Q3	$15.6M	Buy	412,051 +62,288	+18%	+$2.43M	0.13%	143
2013 Q2	$13.7M	Buy	+349,763	New	+$13.6M	0.12%	151

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Westwood Holdings Group's TEVA Position: Q1 2020 in Review

Westwood Holdings Group sold out of Teva Pharmaceuticals (TEVA) in Q1 2020, closing a stake of 13,520 shares — an estimated $132K sold.

Westwood Holdings Group first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $15.6M in Q3 2013. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

Westwood Holdings Group reported no remaining Teva Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Westwood Holdings Group sold 13,520 Teva Pharmaceuticals shares in Q1 2020, an estimated $132K.
Westwood Holdings Group first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Westwood Holdings Group's Teva Pharmaceuticals position peaked at $15.6M in Q3 2013.
459 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on Westwood Holdings Group's 13F filing for Q1 2020, filed 15 May 2020.